Both medications slow gastric emptying, but tirzepatide typically causes more pronounced GI effects
This project was supported in part by NIH Public Health Service grant P30DK056338, which funds the Texas Medical Center Digestive Diseases Center and P30CA125123, which funds the Baylor College of Medicine (BCM) Proteomics Core and its contents are solely the responsibility of the authors and do not necessarily represent the official views of the National Institute of Diabetes and Digestive and Kidney Diseases, National Cancer Institute or the NIH
Heikal, A
This weight loss medication is marketed under several names, including Ozempic and Wegovy
Actual results may differ materially from those contemplated by the forward-looking statements due to the risks and uncertainties described in CVS Healths filings with the Securities and Exchange Commission, including those set forth in the Risk Factors section and under the heading Cautionary Statement Concerning Forward-Looking Statements in our most recent Annual Report on Form 10-K, Quarterly Report on Form 10-Q, and Current Reports on Form 8-K
Thyroid function, reduced kidney function and incident chronic kidney disease in a community-based population: the Atherosclerosis Risk in Communities study